To test whether this increased sirtuin activity was important for the improvement in the swimming of the MJD zebrafish resulting from valproate treatment we performed a co-treatment study involving valproate along with the SIRT1 inhibitor, EX527. The gene discussed is SIRT1; the disease is Spinocerebellar ataxia type 3.